Table 2.
Changes in labortory tests.
Boold test | n | Baseline | Onset of myocarditis | p | Trend | Proportion |
---|---|---|---|---|---|---|
ALC (109/L) | 34 | 1.1 (0.7-1.625) | 0.6 (0.5-1.2) | 0 | decrease | 26 (76.5) |
NLR | 34 | 3.8 (2.35-7.05) | 9.8 (4.8-18.4) | 0 | increase | 29 (85.3) |
CRP (mg/L) | 19 | 13.45 (5.35-62.225) | 31.2 (8.625-94.2) | 0.045 | increase | 12 (63.2) |
LDH (U/L) | 25 | 232.1(184.4-311.15) | 613 (296-1050.8) | 0 | increase | 21 (84.0) |
IL-6 (pg/mL) | 16 | 7.45 (3.725-12.825) | 15.4 (7.075-37.375) | 0.004 | increase | 12 (75.0) |
IL-10 (pg/mL) | 16 | 2.45 (1.475-5.0) | 3.85 (2-7.45) | 0.018 | increase | 13 (81.3) |
CK (U/L) | 27 | 63.2 (49.225-107.0) | 477.2 (101.0-3214.2) | 0 | increase | 23 (85.2) |
CK-MB (U/L) | 21 | 10.0 (2.3-14.0) | 39.0 (17.0-103.45) | 0 | increase | 19 (90.5) |
BNP (pg/mL) | 19 | 103.8 (35.85-258.25) | 1704 (194.1-4848) | 0 | increase | 19 (100.0) |
ALC, absolute lymphocyte count; NLR, neutrophil to lymphocyte ratio; CRP, C-reactive protein; LDH, lactate dehydrogenase; IL-6, interleukin-6; IL-10, interleukin-10; CK, creatine kinase; CK-MB, MB isoenzyme of creatine kinase; BNP, brain natriuretic peptide.